Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
Authors:
- Won Chan LeeWLWon Chan Lee
- Chris L. PashosCPChris L. Pashos
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (10) , 1712-1725
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Management of Type 2 Diabetes in the Primary Care Setting: A Practice-Based Research Network StudyThe Annals of Family Medicine, 2006
- Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analoguesClinical Therapeutics, 2005
- Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin productsCurrent Medical Research and Opinion, 2005
- Preference for insulin delivery systems among current insulin users and nonusersClinical Therapeutics, 2004
- Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitusClinical Therapeutics, 2004
- Hypoglycemia in DiabetesDiabetes Care, 2003
- Before oral agents fail: the case for starting insulin earlyInternational Journal of Obesity, 2002
- Negotiating the Barrier of Hypoglycemia in DiabetesDiabetes Spectrum, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models.Psychological Bulletin, 1995